Literature DB >> 9795966

Green tea and cancer in humans: a review of the literature.

J L Bushman1.   

Abstract

Researchers have investigated green tea as a potential protectant against cancer. This review focuses on studies of green tea in humans. Green tea contains polyphenols, chemicals that act as powerful antioxidants. Epidemiological and human studies have shown varying results. Thirty-one human studies and four reviews were examined. Among five studies reporting on colon cancer, three found an inverse association and one reported a positive association. For rectal cancer, only one of four studies reported an inverse association; increased risks were seen in two of the studies. An inverse association is suggested for urinary bladder cancer in two of two studies. Of 10 studies examining the association of green tea and stomach cancer, 6 suggest an inverse and 3 a positive association. The most comprehensive of these studies supports an inverse association of green tea and stomach cancer. Pancreatic cancer studies hint at an inverse association in two of three studies. A strong inverse effect was found with green tea and esophageal cancer. Lung cancer studies have shown an inverse effect with Okinawan tea, yet tentatively increased risk was shown in another study. Although human studies have their limitations, the research has warranted a further look into the effects of green tea and cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9795966     DOI: 10.1080/01635589809514697

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  42 in total

1.  Synergistic Effects of the Green Tea Extract Epigallocatechin-3-gallate and Taxane in Eradication of Malignant Human Prostate Tumors.

Authors:  Mark E Stearns; Min Wang
Journal:  Transl Oncol       Date:  2011-06-01       Impact factor: 4.243

2.  Tea drinking and the risk of biliary tract cancers and biliary stones: a population-based case-control study in Shanghai, China.

Authors:  Xue-Hong Zhang; Gabriella Andreotti; Yu-Tang Gao; Jie Deng; Enju Liu; Asif Rashid; Kai Wu; Lu Sun; Lori C Sakoda; Jia-Rong Cheng; Ming-Chang Shen; Bing-Sheng Wang; Tian-Quan Han; Bai-He Zhang; Gloria Gridley; Joseph F Fraumeni; Ann W Hsing
Journal:  Int J Cancer       Date:  2006-06-15       Impact factor: 7.396

3.  Green tea drinking and multigenetic index on the risk of stomach cancer in a Chinese population.

Authors:  Li-Na Mu; Qing-Yi Lu; Shun-Zhang Yu; Qing-Wu Jiang; Wei Cao; Nai-Chieh You; Veronica Wendy Setiawan; Xue-Fu Zhou; Bao-Guo Ding; Ru-Hong Wang; Jinkou Zhao; Lin Cai; Jian-Yu Rao; David Heber; Zuo-Feng Zhang
Journal:  Int J Cancer       Date:  2005-10-10       Impact factor: 7.396

Review 4.  Chemoprevention of bladder cancer.

Authors:  Dragan J Golijanin; David Kakiashvili; Ralph R Madeb; Edward M Messing; Seth P Lerner
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

5.  Combination therapy with epigallocatechin-3-gallate and doxorubicin in human prostate tumor modeling studies: inhibition of metastatic tumor growth in severe combined immunodeficiency mice.

Authors:  Mark E Stearns; Michael D Amatangelo; Devika Varma; Chris Sell; Shaun M Goodyear
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

Review 6.  Perspectives for cancer prevention with natural compounds.

Authors:  A R M Ruhul Amin; Omer Kucuk; Fadlo R Khuri; Dong M Shin
Journal:  J Clin Oncol       Date:  2009-05-04       Impact factor: 44.544

Review 7.  Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives.

Authors:  Dale G Nagle; Daneel Ferreira; Yu-Dong Zhou
Journal:  Phytochemistry       Date:  2006-07-31       Impact factor: 4.072

8.  Evaluation of the antioxidant effects of four main theaflavin derivatives through chemiluminescence and DNA damage analyses.

Authors:  Yuan-yuan Wu; Wei Li; Yi Xu; En-hui Jin; You-ying Tu
Journal:  J Zhejiang Univ Sci B       Date:  2011-09       Impact factor: 3.066

Review 9.  Complementary and alternative medications in hepatitis C infection.

Authors:  Dina L Halegoua-De Marzio; Jonathan M Fenkel
Journal:  World J Hepatol       Date:  2014-01-27

10.  Effects of long-term tea polyphenols consumption on hepatic microsomal drug-metabolizing enzymes and liver function in Wistar rats.

Authors:  Tao-Tao Liu; Ning-Sheng Liang; Yan Li; Fan Yang; Yi Lu; Zi-Qing Meng; Li-Sheng Zhang
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.